Single Cord Blood Transplantation Versus HLA-Haploidentical-related Donor Transplantation Using Posttransplant Cyclophosphamide in Patients With Hematological Malignancies-Reference-Cited by-同舟云学术

Single Cord Blood Transplantation Versus HLA-Haploidentical-related Donor Transplantation Using Posttransplant Cyclophosphamide in Patients With Hematological Malignancies

Published:2021-12-20 Issue: Volume:Publish Ahead of Print Page:
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Wada Fumiya,Kanda Junya,Yoshioka Satoshi,Ishikawa Takayuki,Akasaka Takashi,Ueda Yasunori,Hirata Hirokazu,Arai Yasuyuki,Yago Kazuhiro,Anzai Naoyuki,Watanabe Mitsumasa,Ikeda Takashi,Yonezawa Akihito,Imada Kazunori,Itoh Mitsuru,Kitano Toshiyuki,Takeoka Tomoharu,Hishizawa Masakatsu,Nohgawa Masaharu,Arima Nobuyoshi,Asagoe Kousuke,Kondo Tadakazu,Takaori-Kondo Akifumi

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. First complete remission favours haploidentical haematopoietic stem cell transplantation with post‐transplant cyclophosphamide over cord blood transplantation in acute lymphoblastic leukaemia;British Journal of Haematology;2024-02-29

2. Mild Acute Graft-Versus-Host Disease Improves Outcomes After HLA-Haploidentical-Related Donor Transplantation Using Posttransplant Cyclophosphamide and Cord Blood Transplantation;Cell Transplantation;2023-01

3. In 2022, which is preferred: haploidentical or cord transplant?;Hematology;2022-12-09

4. Haplo-Peripheral Blood Stem Cell Plus Cord Blood Grafts for Hematologic Malignancies Might Lead to Lower Relapse Compared with Haplo-Peripheral Blood Stem Cell Plus Bone Marrow Grafts;Transplantation and Cellular Therapy;2022-12